New research led by bioengineers at the University of California San Diego could make it much simpler to repair disease-causing mutations in RNA without compromising precision or efficiency. The new RNA editing technology holds promise as a gene therapy for treating genetic diseases.
Related Articles

News
Meet Dr. Brookie Best, Dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences
August 11, 2022
sandiegobiotech
News, UCSD News
Comments Off on Meet Dr. Brookie Best, Dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences
This month, Brookie Best was named new dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences, succeeding James McKerrow, who stepped down in June after serving as dean for seven years.
[…]

Industry News
UC San Diego Health is First in San Diego to offer CAR T-cell Therapy for Some Cancers
December 3, 2018
sandiegobiotech
Industry News, News
Comments Off on UC San Diego Health is First in San Diego to offer CAR T-cell Therapy for Some Cancers

News
David Victor of UC San Diego to Co-Chair Climate Action Commission
September 29, 2021
sandiegobiotech
News, UCSD News
Comments Off on David Victor of UC San Diego to Co-Chair Climate Action Commission
SAN DIEGO, CA – David G. Victor of the University of California San Diego will bring his years of leadership experience to a new initiative from The American Academy of Arts & Sciences, the Commission on Acceler… […]